Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Pediatr Blood Cancer ; 65(5): e26911, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29314661

RESUMO

BACKGROUND: Hypothalamic obesity (HO) is a major concern in patients treated for craniopharyngioma (CP). The influence of degree of resection on development of HO, event-free survival (EFS), and neuroendocrine sequelae is an issue of debate. PROCEDURE: A retrospective cohort consisting of all CP patients treated between 2002 and 2012 in two university hospitals was identified. Multivariable logistic regression was used to study the associations between preoperative BMI, age at diagnosis, tumor volume, performed surgical resection, and presence of HO at follow-up. RESULTS: Thirty-five patients (21 children and 14 adults) were included. Median follow-up time was 35.6 months (4.1-114.7). Four patients were obese at diagnosis. HO was present in 19 (54.3%) patients at last follow-up of whom eight were morbidly obese. Thirteen (37.1%) patients underwent partial resection (PR) and 22 (62.9%) gross total resection (GTR). GTR was related to HO (OR 9.19, 95% CI 1.43-59.01), but for morbid HO, obesity at diagnosis was the only risk factor (OR 12.92, 95% CI 1.05-158.73). EFS in patients after GTR was 86%, compared to 42% after PR (log-rank 9.2, P = 0.003). Adjuvant radiotherapy after PR improved EFS (log-rank 8.2, P = 0.004). Panhypopituitarism, present in 15 patients, was mainly seen after GTR. CONCLUSIONS: HO is less frequent after PR than after GTR, but PR cannot always prevent the development of morbid obesity in patients with obesity at diagnosis. PR reduces the occurrence of panhypopituitarism. When developing a treatment algorithm, all these factors should be considered.


Assuntos
Craniofaringioma/complicações , Doenças Hipotalâmicas/etiologia , Obesidade/etiologia , Neoplasias Hipofisárias/complicações , Adolescente , Adulto , Criança , Pré-Escolar , Estudos de Coortes , Análise Fatorial , Feminino , Humanos , Doenças Hipotalâmicas/patologia , Masculino , Pessoa de Meia-Idade , Obesidade/patologia , Prognóstico , Fatores de Risco , Adulto Jovem
2.
Pediatr Pulmonol ; 52(6): 729-736, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28076664

RESUMO

INTRODUCTION: Some wheezing toddlers develop asthma later in childhood. Sensitization is known to predict asthma in birth cohorts. However, its predictive value in secondary healthcare is uncertain. AIM: This study examines the predictive value of sensitization to inhalant allergens among wheezing toddlers in secondary healthcare for the development of asthma at school age (≥6 years). METHODS: Preschool children (1-3 years) who presented with wheezing in secondary healthcare were screened on asthma at school age with the International Study of Asthma and Allergies in Childhood questionnaire. The positive and negative predictive value (PPV and NPV) of specific IgE to inhalant allergens (cut-off concentration 0.35 kU/L) and several non-invasive variables from a child's history (such as hospitalization, eczema, and parental atopy) were calculated. The additional predictive value of sensitization when combined with non-invasive predictors was examined in multivariate analysis and by ROC curves. RESULTS: Of 116 included children, 63% developed asthma at school age. Sensitization to inhalant allergens was a strong asthma predictor. The odds ratio (OR), PPV and NPV were 7.4%, 86%, and 55%, respectively. Eczema (OR 3.4) and hospital admission (OR 2.6) were significant non-invasive determinants. Adding sensitization to these non-invasive predictors in multivariate analysis resulted in a significantly better asthma prediction. The area under the ROC curve increased from 0.70 with only non-invasive predictors to 0.79 after adding sensitization. CONCLUSION: Sensitization to inhalant allergens is a strong predictor of school age asthma in secondary healthcare and has added predictive value when combined with non-invasive determinants. Pediatr Pulmonol. 2017;52:729-736. © 2017 Wiley Periodicals, Inc.


Assuntos
Asma/epidemiologia , Hipersensibilidade Imediata/epidemiologia , Sons Respiratórios , Alérgenos/imunologia , Criança , Pré-Escolar , Feminino , Humanos , Imunoglobulina E/imunologia , Lactente , Masculino , Razão de Chances , Curva ROC , Inquéritos e Questionários
3.
J Pediatr Endocrinol Metab ; 28(1-2): 59-63, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25381948

RESUMO

Hypothalamic obesity after treatment for craniopharyngioma is a well-recognized, severe problem. Treatment of hypothalamic obesity is difficult and often frustrating for the patient, the parents and the professional care-giver. Because hypothalamic obesity is caused by an underlying medical disorder, it is often assumed that regular diet and exercise are not beneficial to reduce the extraordinarily high body mass index, and in fact, lifestyle interventions have been shown to be insufficient in case of extreme hypothalamic obesity. Nevertheless, it is important to realize that also in this situation, informal care delivered by the family and appropriate parenting styles are required to minimize the obesity problem. We present a case in which weight gain in the home situation was considered unstoppable, and a very early mortality due to complications of the severe increasing obesity was considered inevitable. A permissive approach toward food intake became leading with rapid weight increase since a restrictive lifestyle was considered a senseless burden for the child. By admission to our hospital for a longer period of time, weight reduction was realized, and the merely permissive approach could be changed into active purposeful care by adequate information, instruction, guidance and encouragement of the affected child and her parents. This case illustrates that, although this type of obesity has a pathological origin, parental and environmental influences remain of extreme importance.


Assuntos
Craniofaringioma/complicações , Doenças Hipotalâmicas/etiologia , Obesidade Mórbida/etiologia , Obesidade Infantil/etiologia , Neoplasias Hipofisárias/complicações , Características de Residência , Criança , Meio Ambiente , Feminino , Humanos , Doenças Hipotalâmicas/diagnóstico , Estilo de Vida , Imageamento por Ressonância Magnética , Poder Familiar , Obesidade Infantil/diagnóstico
4.
J Pediatr Endocrinol Metab ; 28(1-2): 53-7, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25514327

RESUMO

OBJECTIVE: Patients treated for childhood craniopharyngioma often develop hypothalamic obesity (HO), which has a huge impact on the physical condition and quality of life of these patients. Treatment for HO thus far has been disappointing, and although several different strategies have been attempted, all interventions had only transient effects. Since thyroid hormones increase energy expenditure metabolism (thyroid hormone induced thermogenesis), it was speculated that treatment with tri-iodothyronine (T3) may be beneficial. In 2002, a case report was published on reduction of body weight after T3 treatment for HO. No studies have been reported since. Recent experimental studies in rodents showed that T3 increases brown adipose tissue (BAT) activity via (pre)sympathetic pathways between the hypothalamus and BAT. Our aim was to investigate whether T3 treatment increases BAT activity in a patient with HO resulting from (treatment of) childhood craniopharyngioma. METHODS: Thyroxine treatment for central hypothyroidism was switched to T3 monotherapy. Serum T3 and free thyroxine (FT4) concentrations were measured twice weekly for 2 months. ¹²³I-MIBG and ¹8F-FDG-PET after induction of non-shivering thermogenesis for the assessment of sympathetic and metabolic activity of BAT as well as indirect calorimetry for assessment of resting energy expenditure were performed before and during T3 treatment. RESULTS: No change in sympathetic and metabolic BAT activity, energy expenditure, or BMI was seen during T3 treatment despite the expected changes in thyroid hormone plasma concentrations. CONCLUSION: We conclude that T3 monotherapy does not seem to be effective in decreasing HO in childhood craniopharyngioma.


Assuntos
Tecido Adiposo Marrom/efeitos dos fármacos , Craniofaringioma/tratamento farmacológico , Doenças Hipotalâmicas/tratamento farmacológico , Obesidade Infantil/tratamento farmacológico , Neoplasias Hipofisárias/tratamento farmacológico , Tri-Iodotironina/uso terapêutico , Tecido Adiposo Marrom/metabolismo , Tecido Adiposo Marrom/patologia , Criança , Craniofaringioma/complicações , Craniofaringioma/diagnóstico , Metabolismo Energético/efeitos dos fármacos , Feminino , Humanos , Doenças Hipotalâmicas/complicações , Imageamento por Ressonância Magnética , Obesidade Mórbida/complicações , Obesidade Mórbida/diagnóstico , Obesidade Mórbida/tratamento farmacológico , Obesidade Infantil/complicações , Obesidade Infantil/diagnóstico , Neoplasias Hipofisárias/complicações , Neoplasias Hipofisárias/diagnóstico
5.
Ned Tijdschr Geneeskd ; 158(6): A6962, 2014.
Artigo em Holandês | MEDLINE | ID: mdl-24495373

RESUMO

BACKGROUND: Transient global amnesia is a recognised phenomenon in adults. However in children it is rarely described. It is characterised by a sudden loss of memory in an otherwise healthy patient. What is striking is that other cognitive functions and neurological examination are normal. CASE DESCRIPTION: A 9-year-old boy presented at the paediatric ward with acute onset retrograde and anterograde amnesia. He had no history of headache or other (neurological) symptoms. There were no known emotional or physical stressors. A general physical and neurological examination showed no abnormalities. The boy was hospitalised for observation overnight. The next day he was fully recovered. CONCLUSION: Transient global amnesia may occur in childhood. Since patients recover spontaneously, watchful waiting is justified.


Assuntos
Amnésia Global Transitória/diagnóstico , Criança , Cognição/fisiologia , Humanos , Masculino , Transtornos da Memória/diagnóstico , Exame Neurológico , Prognóstico , Conduta Expectante
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...